SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

CytomX Therapeutics, Inc. (CTMX)

CTMX RSS Feed
Add CTMX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 3/21/2017 8:05:26 PM - Followers: 2 - Board type: Free - Posts Today: 0

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition, it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., ImmunoGen, Inc., and The University of Texas M. D. Anderson Cancer Center to develop selected Probody therapeutics. The company was founded in 2008 and is headquartered in South San Francisco, California.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTMX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
CTMX News: Statement of Changes in Beneficial Ownership (4) 04/17/2017 06:26:21 PM
CTMX News: Statement of Changes in Beneficial Ownership (4) 04/14/2017 04:01:13 PM
CTMX News: Statement of Changes in Beneficial Ownership (4) 04/11/2017 12:53:17 PM
CTMX News: Statement of Changes in Beneficial Ownership (4) 04/05/2017 12:19:54 PM
CTMX News: Statement of Changes in Beneficial Ownership (4) 03/31/2017 02:19:37 PM
PostSubject
#2   Bristol-Myers Squibb Company BMY and CytomX Therapeutics, Inc. fl89808 03/21/17 08:05:26 PM
#1   $200M up front payment coming with 36.5 million fl89808 03/20/17 08:06:01 PM
PostSubject